Results 41 to 50 of about 74,576 (156)

Dasatinib and Prednisolone Induction Therapy for a Case of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with Dilated Cardiomyopathy Accompanied by Life-Threatening Ventricular Tachycardia

Case Reports in Hematology, 2017
A 56-year-old man being treated for dilated cardiomyopathy presented with epigastralgia. He was diagnosed with ventricular tachycardia and Philadelphia chromosome-positive acute lymphoblastic leukemia. After treating incessant ventricular tachycardia, we
Mitsutaka Nishimoto, Hirohisa Nakamae, Kana Matsumoto, Kunihiko Morita, Yuki Koga, Dai Momose, Masayuki Hino   +6 more
doaj   +1 more source

Molecular characterization and predictors of relapse in patients with Ph + ALL after frontline ponatinib and blinatumomab

Journal of Hematology & Oncology
Background Several studies have suggested that chemotherapy-free regimens consisting of blinatumomab and a BCR::ABL1 tyrosine kinase inhibitor are highly effective in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL).
Nicholas J. Short, Hagop Kantarjian, Ken Furudate, Nitin Jain, Farhad Ravandi, Omer Karrar, Sanam Loghavi, Lewis Nasr, Fadi G. Haddad, Jayastu Senapati, Rebecca Garris, Koichi Takahashi, Elias Jabbour   +12 more
doaj   +1 more source

Umbilical cord blood transplantation from unrelated donors in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

Haematologica, 2014
There are very few disease-specific studies focusing on outcomes of umbilical cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
José Luis Piñana, Jaime Sanz, Alessandra Picardi, Christelle Ferrá, Rodrigo Martino, Pere Barba, Marta Gonzalez-Vicent, María Jesús Pascual, Carmen Martín, Amparo Verdeguer, Cristina Diaz de Heredia, Pau Montesinos, José-María Ribera, Miguel Sanz, William Arcese, Guillermo Sanz   +15 more
doaj   +1 more source

BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA

Mediterranean Journal of Hematology and Infectious Diseases
Blinatumomab, a CD19-CD3 bispecific T cell engager (BiTE), has two recombinant single-chain variable fragments that temporarily link CD3+ T cells and CD19+ B cells, leading to the T cell-mediated lysis of neoplastic B cells.
Ugo Testa, Elvira Pelosi, Germana Castelli, Patrizia Chiusolo   +3 more
doaj   +1 more source

Chronic myeloid leukemia (CML): prognostic factors and survival analysis

São Paulo Medical Journal
The prognostic value of different factors upon diagnosis of CML was analysed in 45 Philadelphia (Ph1)-positive patients. The median survival was 48 months.
Gisele Wally Braga, Maria de Lourdes Lopes Ferrari Chauffaille, José Eduardo Cajado Moncau, Elizabeth Xisto Souto, Maria Regina Regis Silva, José Kerbauy   +5 more
doaj   +1 more source

PB1757: VARIANT PHILADELPHIA CHROMOSOME IN ALL

HemaSphere, 2022
N. Bouayed Abdelmoula, B. Abdelmoula, A. Sbai, M. Ben ayed, S. Aloulou   +4 more
doaj   +1 more source

PB1891: VARIANT PHILADELPHIA CHROMOSOME IN CML

HemaSphere, 2022
N. Bouayed Abdelmoula, S. Aloulou, B. Abdelmoula   +2 more
doaj   +1 more source

Novel additional cytogenetic abnormalities associated with Philadelphia chromosome

Mediterranean Journal of Hematology and Infectious Diseases, 2014
None
Sanjeev Kumar Sharma, Anil Handoo, Dharma Choudhary, Nitin Gupta   +3 more
doaj  

Treating relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia: liposome-encapsulated vincristine

International Journal of Nanomedicine, 2013
Tyler Davis, Sherif S Farag Department of Internal Medicine, Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, IN, USA Abstract: Acute lymphoblastic leukemia (ALL) remains a disease with poor outcomes in adults ...
Davis T, Farag SS
doaj  

Philadelphia Chromosome [PDF]

, 2020
openaire   +1 more source